News Releases Year None20232022202120202019 Date Title Additional Formats January 8, 2023 Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) January 3, 2023 Phathom Pharmaceuticals Provides Update on New Drug Application Review of Vonoprazan for Erosive Esophagitis Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 12 of 12
